Tellgen Corp (300642) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tellgen Corp (300642) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥36.19 Million ≈ $5.30 Million USD) by net assets (CN¥1.53 Billion ≈ $223.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Tellgen Corp (300642) liquidity interval to measure how many days the company can operate on defensive assets alone.
Tellgen Corp - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Tellgen Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Tellgen Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tellgen Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cotec Construction JSC
VN:CTD
|
-0.185x |
|
DYNAGREEN EN.PR.GR.H YC 1
F:DYN
|
0.037x |
|
Bleichroeder Acquisition Corp. II Class A Ordinary Shares
NASDAQ:BBCQ
|
-0.003x |
|
Text S.A.
WAR:TXT
|
0.303x |
|
Hutchison Telecommunications (Australia) Ltd
AU:HTA
|
0.783x |
|
Giantplus Technology Co Ltd
TW:8105
|
0.004x |
|
Zhubo Design
SHE:300564
|
-0.027x |
|
Bintang Oto Global Tbk PT
JK:BOGA
|
0.031x |
Annual Cash Flow Conversion Efficiency for Tellgen Corp (2012–2025)
The table below shows the annual cash flow conversion efficiency of Tellgen Corp from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 300642 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.48 Billion ≈ $216.63 Million |
CN¥143.23 Million ≈ $20.96 Million |
0.097x | -10.78% |
| 2024-12-31 | CN¥1.52 Billion ≈ $222.14 Million |
CN¥164.62 Million ≈ $24.09 Million |
0.108x | +31.75% |
| 2023-12-31 | CN¥1.54 Billion ≈ $224.72 Million |
CN¥126.40 Million ≈ $18.50 Million |
0.082x | -26.01% |
| 2022-12-31 | CN¥1.48 Billion ≈ $216.67 Million |
CN¥164.72 Million ≈ $24.10 Million |
0.111x | +88.02% |
| 2021-12-31 | CN¥1.40 Billion ≈ $204.32 Million |
CN¥82.61 Million ≈ $12.09 Million |
0.059x | -22.61% |
| 2020-12-31 | CN¥1.27 Billion ≈ $185.34 Million |
CN¥96.83 Million ≈ $14.17 Million |
0.076x | -48.90% |
| 2019-12-31 | CN¥1.17 Billion ≈ $171.01 Million |
CN¥174.84 Million ≈ $25.59 Million |
0.150x | -5.02% |
| 2018-12-31 | CN¥1.02 Billion ≈ $149.87 Million |
CN¥161.32 Million ≈ $23.61 Million |
0.158x | +33.13% |
| 2017-12-31 | CN¥895.86 Million ≈ $131.09 Million |
CN¥106.00 Million ≈ $15.51 Million |
0.118x | -65.30% |
| 2016-12-31 | CN¥288.65 Million ≈ $42.24 Million |
CN¥98.42 Million ≈ $14.40 Million |
0.341x | +1.41% |
| 2015-12-31 | CN¥192.33 Million ≈ $28.14 Million |
CN¥64.67 Million ≈ $9.46 Million |
0.336x | +7.97% |
| 2014-12-31 | CN¥131.05 Million ≈ $19.18 Million |
CN¥40.81 Million ≈ $5.97 Million |
0.311x | +12.41% |
| 2013-12-31 | CN¥95.04 Million ≈ $13.91 Million |
CN¥26.33 Million ≈ $3.85 Million |
0.277x | +193.02% |
| 2012-12-31 | CN¥72.47 Million ≈ $10.60 Million |
CN¥6.85 Million ≈ $1.00 Million |
0.095x | -- |
About Tellgen Corp
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in… Read more